Nuvo Pharmaceuticals Inc NRIFF

RE:RE:Management hired consultants to help!

[mybikeisorange]

John London told me on the phone in February after the WF10 trial failed, that a separate Allergen Chamber arm would be considered in a future WF10 trial. However, he made it clear that the FDA or any other regulatory agency would approve WF10 without meeting efficacy endpoints in a field study. I would not be surprised to see a three-armed study this time around (placebo, field, chamber).  

 

I was also pretty surprised that they will initiate the new trial soon AND have it completed by 4Q 2015. I don't think anyone saw that coming. Most figured they had lost at least 16 months.

 

They had announced previously that they were having an investment bank assist them in planning their next course of action, so that part wasn't a surprise. However, I like the new plan.  Without it, Nuvo is just rotting away with a pot full of cash. Anxious to see them start being more aggressive with P2% in approved territories. Hope we get some developments on that front this year.